Sarepta Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 74 U.S.-traded ETFs. SRPT has around 4.8M shares in the U.S. ETF market. The largest ETF holder of SRPT is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 713.35K shares. Investors may also find of interest that the ETF with the largest allocation to SRPT stock is iShares Genomics Immunology and Healthcare ETF (IDNA), with a portfolio weight of 2.84%. On average, U.S. ETFs allocate 0.34% of SRPT to their portfolios.
Additionally, SRPT is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with SRPT as a holding is the First Trust Lunt U.S. Factor Rotation ETF (FCTR), with a return of 6.79%.